1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in Israel, February 2017

Biotechnology Analysis & Statistics in Israel, February 2017

1-14 of 14 reports

Purchase Reports From Reputable Market Research Publishers

Redhill Biopharma Ltd

Redhill Biopharma Ltd

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Redhill Biopharma Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : Israel
Compugen Ltd

Compugen Ltd

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Compugen Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and ...

  • Countries : Israel
Clal Biotechnology Industries Limited

Clal Biotechnology Industries Limited

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Clal Biotechnology Industries Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biotechnology
  • Countries : Israel
Solegreen Ltd

Solegreen Ltd

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Solegreen Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : Israel
Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016 Summary ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology
  • Countries : World, United States, Japan, Israel
Clal Industries and Investments, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Clal Industries and Investments, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Countries : Israel
Clal Biotechnology Industries, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Clal Biotechnology Industries, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Countries : Israel
ES Cell International Pte., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

ES Cell International Pte., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : Israel, United Kingdom
DeveloGen AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

DeveloGen AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United Kingdom, Germany, Israel
Opportunity Analyzer: Gaucher Disease - Opportunity Analysis and Forecast to 2024

Opportunity Analyzer: Gaucher Disease - Opportunity Analysis and Forecast to 2024

  • $ 10995
  • Industry report
  • December 2015
  • by Global Data

Opportunity Analyzer: Gaucher Disease - Opportunity Analysis and Forecast to 2024 Summary GlobalData estimated the 2014 sales for the Gaucher Disease (GD) market at approximately $875m across the 7MM (US, ...

  • Industries : Pathology, Healthcare
  • Countries : Israel
XTL BIopharmaceuticals Limited

XTL BIopharmaceuticals Limited

  • $ 99
  • Company report
  • November 2015
  • by Wright Investors' Service

A textual analysis of the financial results for XTL BIopharmaceuticals Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biopharmaceutical
  • Countries : Israel
Israel Bio-pharma Research Market - Forecast to 2020

Israel Bio-pharma Research Market - Forecast to 2020

  • $ 2650
  • Industry report
  • October 2015
  • by Micro Market Monitor

The purpose of this report is to cover the definition, description, and forecast of the Israel bio-pharma research market. It involves a deep dive analysis of the market segmentation, which is based on ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : Israel
Protalix BioTherapeutics, Inc. (Israel)

Protalix BioTherapeutics, Inc. (Israel)

  • $ 1550
  • Company report
  • October 2015
  • by Global Industry Analysts

This report presents quick facts about Protalix BioTherapeutics, Inc., which is principally involved in the Manufacture and Distribution of Biopharmaceuticals. Illustrated with 31 tables, the report showcases ...

  • Industries : Biological Therapy
  • Countries : Israel
Recoly N.V. - Product Pipeline Review - 2014

Recoly N.V. - Product Pipeline Review - 2014

  • $ 1500
  • Company report
  • April 2014
  • by Global Markets Direct

Recoly N.V. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Recoly N.V. - Product Pipeline Review - 2014’, provides an overview of the Recoly N.V.’s pharmaceutical research and ...

  • Industries : Biological Therapy, Research and Development, Therapy
  • Countries : World, Israel



Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.